ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard Sees 1Q EPS Of $1.43 To $1.47

By Jon Kamp Of DOW JONES NEWSWIRES C.R. Bard Inc. (BCR) said Monday it expects to post first-quarter earnings in a range of $1.43 to $1.47 per share, which brackets Wall Street expectations. The per-share earnings view excludes any items that could affect comparisons, Chief Financial Officer Todd Schermerhorn said on a call with analysts. Analysts surveyed by Thomson Reuters had forecast, on average, first-quarter earnings of $1.45 per share. Schermerhorn also said the medical-products maker expects sales will grow by 6% to 8% in the current quarter, excluding the impact of foreign currency rates. That is similar to the company's full-year forecast for 5% to 8% sales growth. Bard shares were recently unchanged after hours after rising 1.4% to $94.35 during regular trading hours Monday. Shares have risen 14% over the past 12 months. The Murray Hill, N.J., company reported late Monday that its fourth-quarter earnings rose 29%, topping the company's own estimates. Sales rose 5.9% and were slightly lower than analysts had expected. Schermerhorn said full-year earnings, excluding items, of $5.60 per share serve as a base for the company's full-year projection of 14% growth. -By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
04/24/201309:04:55U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
10/25/201218:32:16High-Grade-Bond Market Absorbs $3.9 Billion of New Deals
06/05/201212:53:24J&J to Stop Selling Surgical Mesh Amid Lawsuits, Concerns -AP
04/21/201200:20:37MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results
01/04/201216:13:14FDA Orders Post-Market Testing Of Surgical Mesh Amid Safety Concerns
12/21/201109:10:36US Stock Futures: HOT STOCKS TO WATCH
10/26/201107:57:35US Stock Futures Higher On Optimism Ahead Of EU Summit
09/14/201114:52:55Erste Group Bank To Buy 24.12% Stake In Romania Unit
09/08/201119:18:41FDA Panel Backs Plans For Premarket Studies Of Organ-Prolapse...
08/01/201110:03:11CR Bard Financial Chief Schermerhorn To Retire
07/21/201117:07:05CR Bard Swings To 2Q Loss On Legal Settlement Charge
06/30/201118:26:54CR Bard In Deal To Settle Hernia Suits, Sees $184 Million 2Q...
04/21/201117:16:41C.R. Bard 1Q Profit Rises 8.8% On Vascular Sales
02/25/201115:05:05Hologic Wins Appellate Ruling In Its Patent Lawsuit
01/31/201118:23:03CR Bard Sees 1Q EPS Of $1.43 To $1.47
01/31/201116:55:19CR Bard 4Q Profit Climbs 29%, Helped By Better Revenue
01/11/201110:04:22CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product
12/13/201017:39:54CR Bard To Cut Jobs In Plan To Improve Cost Structure
10/21/201017:07:47C.R. Bard 3Q Net Down 1.5% On Charges; Sales Fall Short
08/09/201015:22:30FDA Warns About Long-Term Problems With Blood-Clot Device

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad